Skip to content
OpenCapital
Get started

CalAmp CAMP Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

CalAmp logo
CalAmpCAMP
$0-100%
Centerspace logo
CenterspaceCSR
$43K-93.9%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
$0—
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M—
Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$0-100%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%—

Returns & leverage

See full
Return on equity-209.3%—
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: CalAmp’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's exchange offer (note 12)?
CalAmp (CAMP) reported exchange offer (note 12) of $0 in Q4 2025.
How has CalAmp's exchange offer (note 12) changed year-over-year?
CalAmp's exchange offer (note 12) decreased by 100.0% year-over-year, from $40.54M to $0.
What does exchange offer (note 12) mean?
This metric tracks the value of securities or debt instruments converted into common stock, often as part of an exchange offer or restructuring. It highlights changes in the capital structure that reduce debt or preferred equity in favor of common equity. Investors use this to evaluate the impact of balance sheet optimization on equity dilution and financial stability.